Cormorant Asset Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Cormorant Asset Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-25,664	Closed	-$198K	–	58
2023 Q3	$198K	Hold	25,664	–	–	0.01%	49
2023 Q2	$134K	Hold	25,664	–	–	0.01%	64
2023 Q1	$138K	Sell	25,664 -1	-0%	-$5	0.01%	72
2022 Q4	$95K	Hold	25,665	–	–	0.01%	73
2022 Q3	$128K	Hold	25,665	–	–	0.01%	72
2022 Q2	$150K	Hold	25,665	–	–	0.01%	79
2022 Q1	$183K	Hold	25,665	–	–	0.01%	76
2021 Q4	$339K	Hold	25,665	–	–	0.02%	75
2021 Q3	$590K	Hold	25,665	–	–	0.02%	84
2021 Q2	$1.13M	Hold	25,665	–	–	0.04%	97
2021 Q1	$1.86M	Hold	25,665	–	–	0.04%	110
2020 Q4	$1.11M	Hold	25,665	–	–	0.03%	99
2020 Q3	$1.05M	Hold	25,665	–	–	0.04%	89
2020 Q2	$1.54M	Hold	25,665	–	–	0.06%	80
2020 Q1	$1.93M	Sell	25,665 -9,355	-27%	-$1.08M	0.09%	71
2019 Q4	$4.82M	Sell	35,020 -32,513	-48%	-$3.95M	0.19%	60
2019 Q3	$8.02M	Sell	67,533 -5,500	-8%	-$768K	0.49%	49
2019 Q2	$10.2M	Buy	73,033 +8,019	+12%	+$1.41M	0.59%	49
2019 Q1	$11.6M	Buy	65,014 +27,514	+73%	+$4.14M	0.79%	40
2018 Q4	$5.9M	Buy	+37,500	New	+$5.59M	0.48%	43

Other funds holding ORTX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCIA

Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cormorant Asset Management's ORTX Position: Q4 2023 in Review

Cormorant Asset Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2023, closing a stake of 25,664 shares — an estimated $198K sold.

Cormorant Asset Management first reported a position in ORTX in Q4 2018 and held it in 20 quarters. The position peaked at $11.6M in Q1 2019. 47 funds tracked by Wall St. Rank hold ORTX as of Q4 2023.

Cormorant Asset Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2023 after selling out during the quarter.
Cormorant Asset Management sold 25,664 Orchard Therapeutics plc American Depositary Shares shares in Q4 2023, an estimated $198K.
Cormorant Asset Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 20 quarters.
Cormorant Asset Management's Orchard Therapeutics plc American Depositary Shares position peaked at $11.6M in Q1 2019.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2023.

Based on Cormorant Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.